Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003145116 | SCV003832812 | likely pathogenic | Fanconi anemia complementation group C | 2022-08-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003635999 | SCV004436722 | pathogenic | Fanconi anemia | 2023-02-03 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with FANCC-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant is present in population databases (rs758116389, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Gln42*) in the FANCC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCC are known to be pathogenic (PMID: 17924555). |